Red Light Holland announces a partnership with platinum-selling rapper, Wiz Khalifa, to launch Red Light Holland's MISTERCAP brand of psilocybin-based products.
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder
Cybin announces receipt of its "may proceed letter" from the U.S. Food and Drug Administration (FDA) regarding its Phase 1/2a clinical trial of CYB003 for major depressive disorder (MDD).
Numinus Pilots Mental Health Program for Corporate Clients in Utah
Numinus announces a pilot program to encourage employers to offer ketamine-assisted psychotherapy to employees as a health benefit.
Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights
Cybin Inc reports its fiscal year 2022 financial results, including progress on several pipeline initiatives, with a cash balance of CAD$53.6 million as of March 31, 2022.
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) Forum
Better Life Pharma will be presenting an abstract on its lead compound, BETR-001, to the European Neuroscience Societies (FENS) Forum in July.
Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics
Optimi files an application with Health Canada to synthesize, process and produce pharmaceutical grade 3,4-Methylenedioxymethamphetamine ("MDMA").
Numinus completes acquisition of Novamind and announces executive appointments
Numinus Wellness announces the completion of its acquisition of Novamind Inc, with Novamind shareholders receiving 0.84 shares of Numinus per Novamind share.
Cybin Acquires DMT Clinical Study from Entheon Biomedical
Cybin Inc announces acquiring a Phase 1 DMT study from Entheon Biomedical, at a purchase price of CAD$1 million plus additional considerations.
Gold Price Forecast: Gold Recovery Builds Rising Wedge to Resistance
Gold prices have recovered quite a bit since the May low, but that recovery has taken on the form of a rising wedge moving right up to a key level of resistance.
Cybin Announces Publication in Frontiers in Psychology Journal Introducing EMBARK, an Integrative Model of Psychedelic Therapy
Cybin announces publication of EMBARK, a model of psychedelic-assisted psychotherapy that integrates leading clinical approaches to promote effective facilitation and supportive healing.
Gold Fields to become world’s no. 4 gold miner with Yamana acquisition
South African miner Gold Fields is buying Canada’s Yamana Gold in an all-share deal worth $6.7 billion, which will make it the world’s fourth largest gold producer.
Optimi Health Enters Into Psilocybin Supply Agreement With Filament Health
Optimi Health announces a new supply agreement with Filament Health to supply Filament with psilocybin mushrooms.
